Tango Therapeutics, Inc. (TNGX) Debt Components
- 2021-06-30: Debt Instrument, Convertible, Conversion PriceUSD/shares 10.00; Debt Instrument, Unused Borrowing Capacity, FeeUSD (m).
- 2021-03-31: Debt Instrument, Convertible, Conversion PriceUSD/shares 10.00; Debt Instrument, Unused Borrowing Capacity, FeeUSD (m).
- 2020-12-31: Debt Instrument, Convertible, Conversion PriceUSD/shares (m); Debt Instrument, Unused Borrowing Capacity, FeeUSD 7 month · $127.00K.
- 2020-12-31: Debt Instrument, Convertible, Conversion PriceUSD/shares 10.00; Debt Instrument, Unused Borrowing Capacity, FeeUSD (m).
Tango Therapeutics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Debt Instrument, Convertible, Conversion Price USD/shares | Debt Instrument, Unused Borrowing Capacity, Fee USD |
|---|---|---|
| 2021-06-30 | 10.00 | (m) |
| 2021-03-31 | 10.00 | (m) |
| 2020-12-31 | (m) | 7 month · $127.00K |
| 2020-12-31 | 10.00 | (m) |
| 2020-09-30 | (m) | 4 month · $127.00K |
| 2020-09-30 | 10.00 | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |